Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Panacea Life Sciences's price to sales ratio was 0.5× on Oct 19, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.2× to 4.4×, with a median of 0.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.5× | +0.1 |
| 2025 | Dec 31, 2025 | 0.3× | +0.2 |
| 2024 | Dec 31, 2024 | 0.2× | −1.3 |
| 2023 | Dec 29, 2023 | 1.5× | +1.0 |
| 2022 | Dec 30, 2022 | 0.5× | – |
See a number that looks wrong?